Happy #OPRD Items of Interest Day!
Another wholesome set of fantastic chemistry highlights and I’m not just saying that because we’ve made this issue…
(Ok maybe a bit) #ChemSky
🚨 Call for Short Papers – Communications & Technical Notes
Have a breakthrough that doesn’t fit a full-length article? #OPRD is now accepting Communications and Technical Notes—short, focused papers designed to move ideas forward faster.
👉 axial.acs.org/organic-chem...
My favorite 2025 #PfizerChemistry publications #12daysOfPapers 5/n:
From Pfizer Boulder-this #OPRD has it all-enablement, sp2/sp3 hets, cross electrophile couplings, SnAr and more - nice work from @ronhinklin.bsky.social and all
#ChemSky #ChemChat
My favorite 2025 #PfizerChemistry publications #12daysOfPapers 4a/n:
The Copper Crew from our Process chem department teamed up again for another #OPRD paper on Cu-catalyzed coupling this time enabling 2° amines with very mild conditions
#ChemSky #ChemChat
My favorite 2025 #PfizerChemistry publications #12daysOfPapers 4/n:
From our Process chem colleagues comes this wonderful #OPRD paper on Cu-catalyzed ammonia/small amine couplings - tons of het scope, easy set up (even worked for me!)
#ChemSky #ChemChat
My favorite 2025 #PfizerChemistry publications #12daysOfPapers 3/n:
MedChem and Process working together to enable chiral cyclopropanes for pre-clinical scaleup - route scouting and development with great teamwork #OPRD #ChemSky #ChemChat
Sign up for our ACS Publications Industry Webinar where we will have #OPRD author Yuhei Yamamoto describe a real-world case study on scale-up of Suzuki-Miyaura couplings.
December 11, 2025 at 9 AM Japan Standard Time (December 10, 2025 at 7 PM ET / 4 PM PT)
access.acspubs.org/SuzukiMiyaur...
Nominate Articles for the #OPRD 2026 Outstanding Paper of the Year Award by Dec 31!
The award winner will receive:
- $2000 USD prize
- Complimentary travel and registration to ACS Fall 2026 in Chicago to deliver the award lecture
- Award plaque
americanchemical.co1.qualtrics.com/jfe/form/SV_...
"Failure is the mother of success" -- Read case studies highlighting the knowledge gained from failures and unexpected results in this Lessons Learned in Organic Process Chemistry Special Issue in #OPRD @pubs.acs.org
pubs.acs.org/page/oprdfk/...
This month's #OPRD Items of Interest is out!
pubs.acs.org/doi/10.1021/...
I read #OPRD every day and have found some of the best, most useful synthetic chemistry on its pages
If you need to see how useless IF is then look at these scores
OPRD IF = 3.5
CiteScore = 5.4
(I realize that it’s mainly papers from my industry - it’s still a poor metric for an awesome journal)
Looking to couple small amines? Even NH3? Super #OPRD from some of my #PfizerChemistry friends with picolinamide ligands for Cu couplings at low %, hi yields/scope-all those hets! So easy I used it to make [REDACTED] inhibitors
This is who I go to for advice – top chemists and friends
#ChemPubs
A very big congrats to the #OPRD winners of the Outstanding Publication of the Year Award, co-sponsored by the ACS Division of Organic Chemistry: Dr. Hsiao-Wu Hsieh and colleagues!
axial.acs.org/organic-chem...
Check out our latest joint Special Issue between #JOrgChem and #OPRD: Excellence in Industrial Organic Synthesis! This is the third edition of this special issue highlighting the industrially relevant work in organic synthesis today.
pubs.acs.org/page/vsi/exc...
wondering why i havent seen #OPRD posts in a while and realised that #OPRD isn't on #ChemSky (I think they are still on the OTHER place)
Another #OPRD asap to highlight is this one from #PfizerChemistry showing a kilo scale route to complex API with all kinds of cool - small hets (pyrazoles!) cyBu, Weix cross electrophile coupling, key synthesis improvements driven by reaction safety…so much to discover in this one #ChemSky
Also in #OPRD asap is this fantastic manuscript from our friends at Enamine 🇺🇦 outlining improvements allowing a scalable synthesis for Rawal’s diene - some very cool chemistry in here - well done Serhiy, Dima and the crew at Enamine #ChemSky
The April 2025 edition of #OPRD Items of Interest is online chock full of useful synthesis highlights for #ChemSky - too many to list off here (but you might find a couple from #PfizerChemistry)
Definitely worth a look at the cool chem in this issue
Wonderful #OPRD from #PfizerChemistry (UK) with Snapdragon prepping a key intermediate using process safety endpoints as part of DOE studies #MyOtherCompoundIsAKetal
#ChemSky Super #OPRD out today from #LillyChem on an IL17 compound from discovery to process chem. A ln extensive look at all the chemistry needed to bring this complex API to key preclinical studies
A great read!
Chiral cyclopropanes?
We got em - check out this new #OPRD from my #PfizerChemistry colleages from MedChem, HTE, Biocatalysis and Process coming together to enable a wonderful method to key fragments. Neat story on how it all came together (chiral Corey-Chaykovsky alert!)
For #ChemSky #SynthesisSaturday here’s a very cool #OPRD on a process scalemacrocycle from GSK and my pal Ollie Ring
I’ve seen this story in talk form and there’s some excellent chemistry in here
Check out both of the Items of Interest Highlights articles in this month's #OPRD issue:
pubs.acs.org/doi/10.1021/...
pubs.acs.org/doi/10.1021/...
Special Issue Alert! Analytical control strategies play a major role in quality assurance and reaction monitoring in modern process chemistry.
Analytical Control Strategies for Process Chemists in #OPRD
Special Issue: pubs.acs.org/page/oprdfk/...
Editorial: pubs.acs.org/doi/10.1021/...
#ChemSky
KANEKA introduces a stereoselective synthesis of mirogabalin featuring a novel stereo- and 1,4-selective addition of lithioacetonitrile to alkylidene malonate #OPRD #chemsky
pubs.acs.org/doi/10.1021/...
This is a very cool #OPRD showing some excellent enablement of a small piece of a drug candidate from my former #PfizerChemistry colleagues in Sandwich UK.
See also: “Oh cute Medchem route…here’s 6 papers with better chemistry”
[Narrator: it was the Medchem route from Scott’s lab]
The development story behind the second generation synthesis of Cognition Therapeutics' sigma-2 receptor modulator, zervimesine (CT1812) can be found here:
pubs.acs.org/doi/10.1021/...
#chemsky #OPRD